The study marks a new standard for inclusive medicine with recruitment for target demographics reaching over 3x the national average
October 10, 2023
Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study
October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the…
Read More
Primary endpoint, six-month clinical and imaging data from clinical trial of DESyne BDS Plus stent system evaluating safety and efficacy of localized delivery of anticoagulants and an anti-proliferative agent designed to reduce the implant thrombotic risk
October 10, 2023
Elixir Medical To Present Randomized Clinical Dataset Featuring World’s First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023
October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present…
Read More
October 10, 2023
Cardiovascular Research Foundation Announces TCT 2023 Award Winners
October 10, 2023 — The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O.…
Read More
World Stroke Day October 29, 2023
October 10, 2023
Philips in Partnership with the World Stroke Organization: Putting Stroke on the Global Agenda
The global incidence of non-communicable diseases (NCDs) is currently around 40 million cases a year. Of that total,…
Read More
The program is recommended by the Centers for Medicare and Medicaid services for patients who undergo heart valve repair or replacement
October 09, 2023
TAVR: Less Than One-third of Patients Enter Cardiac Rehab After Heart Procedure
October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not…
Read More
Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a mouse model of arrhythmogenic cardiomyopathy (ACM)
October 09, 2023
Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy
October 9, 2023 — Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key…
Read More
Endotronix announced FDA approval for the PROACTIVE-HF 2 IDE trial with the Cordella Sensor to expand market access and shared positive results from a substudy of their pivotal PROACTIVE-HF clinical trial. The company plans to share full results from the PROACTIVE-HF trial next year.
October 09, 2023
Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
October 9, 2023 — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the…
Read More
Adel Younoszai, MD
October 06, 2023
Rady Children’s Appoints Adel Younoszai, MD, as Rady Children’s Hospital Co-Director of the Heart Institute, and Division Chief of Cardiology, Department of Pediatrics, UC San Diego
October 6, 2023 —  Rady Children’s Hospital-San Diego, the largest children’s hospital on the West Coast and one of the…
Read More
Retrospective study of over 18,000 drug-refractory AFib patients found those treated with catheter ablation had a 57% lower risk of developing heart failure compared to those receiving antiarrhythmic drugs 
October 06, 2023
Biosense Webster Study Links Lower Risk of Heart Failure in Atrial Fibrillation Patients Treated with Catheter Ablation Compared to Antiarrhythmic Drugs
October 6, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers to perform cardiac exams with real-time guidance at the point of care
October 06, 2023
GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance
October 6, 2023 — GE HealthCare announced its Venue Family point-of-care ultrasound systems will now feature Caption…
Read More
Here is a look at the most-read content during the month of September on dicardiology.com.
By Melinda Taschetta-Millane
October 06, 2023
Top 10 for September
Here is a look at the most-read content during the month of September on dicardiology.com. 1. Cardiovascular…
Read More
Offering healthcare facilities with the option to either use a flexible daily-leased rubidium program or build a full time PET program will ultimately increase access for suspected CAD patients to state of the art imaging with cardiac PET.
October 05, 2023
Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an…
Read More
The conference focuses on the enduring value of ACC Accreditation and NCDR services for achieving quality care
October 05, 2023
ACC Quality Summit Explores Practical Strategies to Reboot and Rebrand Healthcare Quality
October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando,…
Read More
According to new research published in Mayo Clinic Proceedings, calculating the patient's mean arterial pressure (AugMAP) is a simple and effective way to identify those patients who may benefit from more aggressive treatment strategies.
October 05, 2023
Mayo Clinic Researchers Develop Calculation to Identify High-risk Moderate Aortic Stenosis Patients
October 5, 2023 — Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis …
Read More
Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure
October 04, 2023
Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction
October 4, 2023 — Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in…
Read More
2023 MedAxiom Cardiovascular Provider Compensation and Production Survey Report aggregates data on private vs. integrated practice, APP to physician ratios, patient volumes and subspeciality considerations
October 04, 2023
Cardiology Compensation and Production Remain Relatively Stable Year-over-year
October 4, 2023 — MedAxiom, a premier source for cardiovascular organizational performance solutions, has released its…
Read More
Nearly 900 Butterfly devices have been distributed throughout Ukraine via global health partnerships, with Razom alone contributing more than 400 units
October 04, 2023
Butterfly Network and Razom Expand Global Health Partnership To Bring Additional 200 Butterfly iQ+ Ultrasound Systems to Ukraine
October 4, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable,…
Read More
October 04, 2023
JACC Issues Scientific Statement Exploring Impact of dLVAD on Quality of Life for HF Patients
October 5, 2023 — A newly-issued "Scientific Statement on Durable Mechanical Circulatory Support" in the October issue…
Read More
October 04, 2023
American College of Cardiology and Serv Medical Announce Collaboration on Digital Health Care Innovation
October 4, 2023 — The American College of Cardiology (ACC) recently announced that it has started a strategic…
Read More
EnCompass plans to immediately initiate clinical site start-up activities in the US
October 03, 2023
EnCompass receives FDA conditional IDE approval to commence a US pilot study of its F2 cerebral embolic protection (CEP) system in patients undergoing transcatheter aortic valve replacement (TAVR)
October 3, 2023 — EnCompass Technologies, Inc., a privately held medical device company focused on protecting patients…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now